These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38335808)

  • 21. BCL9 is an essential component of canonical Wnt signaling that mediates the differentiation of myogenic progenitors during muscle regeneration.
    Brack AS; Murphy-Seiler F; Hanifi J; Deka J; Eyckerman S; Keller C; Aguet M; Rando TA
    Dev Biol; 2009 Nov; 335(1):93-105. PubMed ID: 19699733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy.
    Brown TC; Nicolson NG; Korah R; Carling T
    J Am Coll Surg; 2018 Jun; 226(6):988-995. PubMed ID: 29428231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p/BCL9 axis to activate the Wnt/β-catenin signaling.
    Guan B; Ma J; Yang Z; Yu F; Yao J
    Environ Toxicol; 2021 Aug; 36(8):1640-1653. PubMed ID: 33974352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissecting the geometric and hydrophobic constraints of stapled peptides.
    Li J; Tan YS; Verma CS
    Proteins; 2025 Jan; 93(1):287-301. PubMed ID: 38196284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted β-catenin ubiquitination and degradation by multifunctional stapled peptides.
    Wang X; Dong L; Cheng J; Verdine GL; Lin A; Chu Q
    J Pept Sci; 2022 Jul; 28(7):e3389. PubMed ID: 34937123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rational design of selective small-molecule inhibitors for β-catenin/B-cell lymphoma 9 protein-protein interactions.
    Hoggard LR; Zhang Y; Zhang M; Panic V; Wisniewski JA; Ji H
    J Am Chem Soc; 2015 Sep; 137(38):12249-60. PubMed ID: 26352795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and biological evaluation of quercetin derivatives as novel β-catenin/B-cell lymphoma 9 protein-protein interaction inhibitors.
    Shen LA; Peng X; Bao Y; Liu C; Zhang H; Li J; Zhu D; Zhang Q
    Eur J Med Chem; 2023 Feb; 247():115075. PubMed ID: 36599228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a penetratin-conjugated stapled peptide that inhibits Wnt/β-catenin signaling.
    Tsuchiya K; Kiyoshi M; Hashii N; Fujita M; Kurohara T; Ishii-Watabe A; Fukuhara K; Misawa T; Demizu Y
    Bioorg Med Chem; 2022 Nov; 73():117021. PubMed ID: 36198218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological inhibition of β-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating T
    Feng M; Jin JQ; Xia L; Xiao T; Mei S; Wang X; Huang X; Chen J; Liu M; Chen C; Rafi S; Zhu AX; Feng YX; Zhu D
    Sci Adv; 2019 May; 5(5):eaau5240. PubMed ID: 31086813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis.
    Shang Z; Zhao J; Zhang Q; Cao C; Tian S; Zhang K; Liu L; Shi L; Yu N; Yang S
    J Biol Chem; 2019 Jun; 294(25):9844-9857. PubMed ID: 31073027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis of beta-catenin recognition by Tax-interacting protein-1.
    Zhang J; Yan X; Shi C; Yang X; Guo Y; Tian C; Long J; Shen Y
    J Mol Biol; 2008 Dec; 384(1):255-63. PubMed ID: 18835279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of 2-(3-(3-Carbamoylpiperidin-1-yl)phenoxy)acetic Acid Derivatives as Novel Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
    Wang Z; Zhang M; Luo W; Zhang Y; Ji H
    J Med Chem; 2021 May; 64(9):5886-5904. PubMed ID: 33902288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma.
    Huge N; Sandbothe M; Schröder AK; Stalke A; Eilers M; Schäffer V; Schlegelberger B; Illig T; Vajen B; Skawran B
    Hepatol Int; 2020 May; 14(3):373-384. PubMed ID: 31440992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid.
    de la Roche M; Rutherford TJ; Gupta D; Veprintsev DB; Saxty B; Freund SM; Bienz M
    Nat Commun; 2012 Feb; 3():680. PubMed ID: 22353711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of Novel 1-Phenylpiperidine Urea-Containing Derivatives Inhibiting β-Catenin/BCL9 Interaction and Exerting Antitumor Efficacy through the Activation of Antigen Presentation of cDC1 Cells.
    Zhu W; Liu C; Xi K; Li A; Shen LA; Li Y; Jia M; He Y; Chen G; Liu C; Chen Y; Chen K; Sun F; Zhang D; Duan C; Wang H; Wang D; Zhao Y; Meng X; Zhu D
    J Med Chem; 2024 Aug; 67(15):12485-12520. PubMed ID: 38912577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma.
    Xu W; Zhou W; Cheng M; Wang J; Liu Z; He S; Luo X; Huang W; Chen T; Yan W; Xiao J
    Sci Rep; 2017 Jan; 7():40446. PubMed ID: 28074862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Method to Calculate the Relative Binding Free Energy Differences of α-Helical Stapled Peptides.
    Valiente PA; Becerra D; Kim PM
    J Org Chem; 2020 Feb; 85(3):1644-1651. PubMed ID: 31893470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aristaless Related Homeobox (ARX) Interacts with β-Catenin, BCL9, and P300 to Regulate Canonical Wnt Signaling.
    Cho IT; Lim Y; Golden JA; Cho G
    PLoS One; 2017; 12(1):e0170282. PubMed ID: 28103279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-Based Optimization of Small-Molecule Inhibitors for the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
    Zhang M; Wang Z; Zhang Y; Guo W; Ji H
    J Med Chem; 2018 Apr; 61(7):2989-3007. PubMed ID: 29566337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico optimization of peptides that inhibit Wnt/β-catenin signaling.
    Fujita M; Tsuchiya K; Kurohara T; Fukuhara K; Misawa T; Demizu Y
    Bioorg Med Chem; 2023 Apr; 84():117264. PubMed ID: 37003158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.